Professor Joan Costa-Font works at LSE as a Professor of Health Economics, and team leader of the ageing and health incentives unit (AHIL) in the Department of Health Policy where he is Co-director of the MSc International Health Policy. Joan has been Harkness Fellow at Harvard University and currently, he is a CESifo and IZA network research fellow, and has been Harkness Fellow at Harvard University and visiting fellow at UCL, Boston College, Oxford University (IA) and the University of Munich (CES).
Professor Costa-Font earned three undergraduate and research degrees, in economics, law and political science a master's degree in economic analysis from Universitat Pompeu Fabra, and an MSc (Econ) in international health policy (specialising in health economics and public economics). After completing a PhD in economics, in 2001 he earned a Marie Curie Postdoctoral Fellowship based at LSE and taught microeconomics and health economics as a tenured associate professor at the University of Barcelona before joining LSE in 2007, initially as a lecturer, and later as senior lecturer (2010) and then reader (2012). He has been a consultant to the WHO, the World Bank, the Latin-American Development Bank, OECD, European Commission and private originations.
Expertise: behavioural incentives; ageing, long-term care, health disadvantage; healthy lifestyles; preventative health care, health behaviours (smoking, obesity, sleep, food, exercise).
LSE Consulting projects:
Children's Wellbeing and Development Outcomes for Ages 5, 7 and 11, and their Predictors
Public Health England, March 2016 - April 2018
Social Policy Reforms in the EU: A Cross-national Comparison
BertelsmannStiftung, October 2015
A Common Disease with Uncommon Treatment: European Guideline Variations and access to innovative therapies for Rheumatoid Arthritis
Policy Analysis Centre, July 2012
Measures to Promote the Situation of Roma EU Citizens in the European Union
European Parliament - DG for Internal Policies, January 2011
Pharmaceutical Reimbursement Policy in Turkey
New Hope in Health Foundation (SUVAK), September 2005
The Economic Impact of Pharmaceutical Parallel Trade in European Union Member States: A Stakeholder Analysis
Johnson & Johnson, January 2004